TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.229
+0.019 (1.55%)
May 6, 2026, 12:12 PM EDT - Market open
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $73.85 million as of May 6, 2026. Its market cap has decreased by -14.70% in one year.
Market Cap
73.85M
Enterprise Value
14.45M
1-Year Change
-14.70%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $73.85M, a decrease of -79.43%. That is a compound annual growth rate of -28.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 72.72M | 28.15% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 78.21M |
| XBiotech | 77.74M |
| Rallybio | 75.54M |
| Q32 Bio | 75.20M |
| Pliant Therapeutics | 74.92M |
| PMV Pharmaceuticals | 73.06M |
| Actuate Therapeutics | 72.79M |
| OS Therapies | 72.73M |